Small-scale Bioreactors Market Size & Growth Forecast 2027–2036, By Segments (End Use, Capacity, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Small-scale Bioreactors Market size was more than USD 1.3 billion in 2026 and is set to grow at a 8.93% CAGR between 2027 and 2036, reaching USD 3.06 billion by 2036. The industry revenue for 2027 is assessed at USD 1.4 billion.
Get more details on this report
Request Free Sample ReportSmall-scale Bioreactors Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 48.47% of the market in 2026, supported by its mature biopharmaceutical sector, advanced research infrastructure, and sustained investment in biologics development and pilot-scale bioprocessing.
- Asia Pacific is forecast to expand at a 16.35% CAGR, driven by growing biopharmaceutical manufacturing, rising contract research activity, and wider adoption of compact bioprocessing systems across research and production facilities.
Segment Momentum
- CROs and CMOs held a 47.94% share in 2026 because they manage multiple outsourced biologics programs and rely on flexible small-scale bioreactors for efficient process optimization and bench-scale development.
- The 3L-5L capacity segment is expanding fastest as users seek higher culture volumes that better support scale-up evaluation while maintaining the flexibility of small-scale bioprocessing environments.
Market Expansion Drivers
- Expanding biopharmaceutical R&D accelerating process optimization using small-scale bioreactor systems.
- Rising adoption of single-use bioreactors in CROs and CMOs improving production flexibility.
- Growth in biologics and cell therapy pipelines driving advanced bioprocess development tools.
Leading Market Participants
- Major companies in the small-scale bioreactors market include Sartorius AG (Germany), Thermo Fisher Scientific Inc. (United States), Merck KGaA (Germany), Danaher Corporation (United States), Eppendorf SE (Germany), Getinge AB (Sweden), INFORS HT (Switzerland), Solaris Biotechnology Srl (Italy), LAMBDA Instruments GmbH (Switzerland), Solida Biotech GmbH (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.3 billion
- 2027 Estimated Market Size: USD 1.4 billion.
- Projected Market Size: USD 3.06 billion by 2036
- Growth Forecast: 8.93% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: CROs & CMOs (End Use) | 1L-3L (Capacity) | Single-use Bioreactors (Product)
- Emerging Opportunity Segment: Academic & Research Institutes (End Use) | 3L-5L (Capacity) | Reusable Bioreactors (Product)
Market Growth Drivers and Industry Trends
Expanding biopharmaceutical R&D accelerating process optimization using small-scale bioreactor systems
Expanding biopharmaceutical R&D will accelerate small-scale bioreactors market growth as developers require flexible systems for optimizing biological processes before advancing them toward larger-scale production. Small-scale platforms allow researchers to examine process conditions and refine bioprocess parameters efficiently, supporting development activities where controlled experimentation and process optimization are essential to improving production approaches and reducing uncertainty during development.
Rising adoption of single-use bioreactors in CROs and CMOs improving production flexibility
The small-scale bioreactors market is benefiting from rising adoption of single-use bioreactors across CROs and CMOs, where flexible production capabilities are increasingly important for handling diverse development and manufacturing requirements. Single-use systems can support adaptable workflows and reduce the operational constraints associated with reusable equipment, making them suitable for organizations managing multiple processes, projects, or production requirements with varying operational needs.
Growth in biologics and cell therapy pipelines driving advanced bioprocess development tools
Growth in biologics and cell therapy pipelines will support small-scale bioreactors market demand by increasing the need for advanced tools capable of supporting complex bioprocess development. As development programs require controlled cultivation and process refinement, small-scale bioreactor systems provide a practical environment for evaluating and optimizing production conditions, supporting research teams as they advance biologics and cell therapy processes through development stages.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expansion of biopharmaceutical production | 5.00% | Short term (≤ 2 yrs) | North America, Europe | Medium | Fast |
| Technological innovations in bioreactors | 5.00% | Medium term (2–5 yrs) | North America, Asia Pacific | Low | Moderate |
| Adoption of small-scale bioreactors in emerging markets | 4.60% | Long term (5+ yrs) | Asia Pacific, Latin America | Low | Slow |
| Expanding biopharmaceutical R&D accelerating process optimization using small-scale bioreactor systems | 2.00% | Moderate | North America, Europe | High | Near Term |
| Rising adoption of single-use bioreactors in CROs and CMOs improving production flexibility | 1.70% | Low | North America, Asia Pacific | High | Near Term |
| Growth in biologics and cell therapy pipelines driving advanced bioprocess development tools | 1.50% | Moderate | Europe, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
Holding the largest share of the small-scale bioreactors market, North America accounted for 48.47% in 2026, supported by a well-developed biotechnology ecosystem and extensive research activity across biopharmaceutical development. Small-scale bioreactors are widely suited to laboratory experimentation, process optimization, cell culture research, and early-stage development, making them valuable within research-intensive environments. Strong investment in advanced bioprocessing infrastructure, increasing adoption of cell-based research, and demand for scalable manufacturing workflows are contributing to regional adoption. The presence of sophisticated academic and pharmaceutical research facilities, combined with growing interest in process automation and reproducibility, is further strengthening North America's position in this market.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, benefiting from expanding biopharmaceutical research capabilities, increasing investment in biotechnology infrastructure, and the development of domestic manufacturing capacity. Greater attention to biologics, cell-based processes, and advanced research applications is encouraging laboratories and production facilities to adopt flexible bioprocessing technologies. Small-scale bioreactors offer an efficient platform for experimentation and process development, making them increasingly relevant as regional organizations build capabilities across the biopharmaceutical value chain. Growing technical expertise, improving research infrastructure, and expanding support for biotechnology innovation are creating a favorable environment for wider adoption across Asia Pacific.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Process Development ExcellenceGermany emphasizes small-scale bioreactors that support efficient upstream process development and biomanufacturing innovation. German biotechnology companies seek highly controlled systems that generate reliable experimental data and streamline scale-up activities.
France 🇫🇷
Collaborative Bioprocess ResearchFrance promotes small-scale bioreactors within academic and industrial biotechnology collaborations focused on advanced therapeutic development. French laboratories increasingly adopt automated platforms that improve experimental consistency and accelerate process refinement.
Italy 🇮🇹
Flexible Laboratory ProductionItaly is expanding the use of small-scale bioreactors for pharmaceutical and biotechnology research requiring adaptable cultivation systems. Italian organizations emphasize operational simplicity, reliable monitoring, and scalable process development for specialized biological products.
Japan 🇯🇵
Efficient Research WorkflowsJapan adopts small-scale bioreactors to improve laboratory productivity and optimize complex bioprocesses. Japanese research institutions value compact, automated systems that deliver consistent cultivation performance while reducing resource consumption during development programs.
South Korea 🇰🇷
Biotech Capacity ExpansionSouth Korea continues investing in small-scale bioreactors to strengthen biopharmaceutical research and manufacturing capabilities. Organizations prioritize flexible systems supporting rapid process optimization, cell culture development, and efficient transition to larger production environments.
United States 🇺🇸
Bioprocess Innovation PlatformThe U.S. is expanding use of small-scale bioreactors for biologics development, cell therapy research, and process optimization. Research organizations prioritize scalable systems that accelerate experimentation while improving reproducibility and technology transfer to commercial manufacturing.
Segment Leadership and Growth Trends
Small-scale Bioreactors Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: CROs & CMOs (Largest Segment) vs Academic & Research Institutes (Fastest-Growing Segment)
The CROs & CMOs segment led the small-scale bioreactors market with a 47.94% share in 2026, supported by increasing outsourcing of bioprocess development, process optimization, and early-stage manufacturing activities. Small-scale bioreactors provide these organizations with flexible platforms for cell culture experimentation, process development, and reproducibility testing while reducing resource requirements during development stages. Their ability to support controlled experimentation and scalable bioprocess workflows makes them particularly valuable for contract organizations serving diverse biotechnology and pharmaceutical development programs.
Academic & research institutes represent the fastest-growing segment as research organizations increasingly adopt small-scale bioreactor systems for laboratory-based cell culture, microbial studies, and bioprocess research. These systems allow researchers to evaluate biological processes under controlled conditions while facilitating experimentation with different process parameters and culture approaches. Growing interest in advanced biotechnology research, personalized biological studies, and process innovation is further encouraging the use of compact bioreactor platforms across research environments.
Capacity Segment Analysis: 1L-3L (Largest Segment) vs 3L-5L (Fastest-Growing Segment)
Holding the largest share of the small-scale bioreactors market, the 1L-3L capacity segment accounted for 32.3% in 2026. This capacity range provides a practical balance between laboratory-scale experimentation and meaningful process development, making it suitable for research, optimization, and early-stage bioprocess activities. Its manageable size, efficient resource utilization, and suitability for controlled cell culture experiments support adoption among organizations seeking reproducible results without the operational demands associated with larger systems.
The 3L-5L capacity segment is growing at the fastest pace as bioprocess developers increasingly require larger experimental volumes to validate process conditions before moving toward broader production environments. This capacity range offers greater flexibility for process optimization while maintaining the controlled conditions associated with small-scale systems. Increasing emphasis on improving scalability, reproducibility, and process consistency is supporting demand for bioreactors that can bridge laboratory research and subsequent manufacturing development.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes | CROs & CMOs | Academic & Research Institutes |
| Capacity | 5 ML-100 ML, 100 ML-250 ML, 250 ML-500 ML, 500 ML-1 L, 1L-3L, 3L-5L | 1L-3L | 3L-5L |
| Product | Reusable Bioreactors, Single-use Bioreactors | Single-use Bioreactors | Reusable Bioreactors |
Competitive Landscape and Market Positioning
Top players in the small-scale bioreactors market:
1. Sartorius AG (Germany)
2. Thermo Fisher Scientific Inc. (United States)
3. Merck KGaA (Germany)
4. Danaher Corporation (United States)
5. Eppendorf SE (Germany)
6. Getinge AB (Sweden)
7. INFORS HT (Switzerland)
8. Solaris Biotechnology Srl (Italy)
9. LAMBDA Instruments GmbH (Switzerland)
10. Solida Biotech GmbH (Germany)
The small-scale bioreactors market is expanding due to rising demand in biopharmaceutical research and production optimization. Advanced control systems are improving process reproducibility and scalability. The small-scale bioreactors market is also witnessing innovation in modular bioprocess design. Focus remains on enhancing experimental flexibility and efficiency.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Sartorius AG (Germany) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Merck KGaA (Germany) | |||||||
| Danaher Corporation (United States) | |||||||
| Eppendorf SE (Germany) | |||||||
| Getinge AB (Sweden) | |||||||
| INFORS HT (Switzerland) | |||||||
| Solaris Biotechnology Srl (Italy) | |||||||
| LAMBDA Instruments GmbH (Switzerland) | |||||||
| Solida Biotech GmbH (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Thermo Fisher Scientific | Apr-25 | Thermo Fisher Scientific introduced the 5L DynaDrive single-use bioreactor to improve scalability and efficiency in bioprocess development. The system enables scale-up from 1 to 5,000 liters and is designed for biopharmaceutical manufacturers and CDMOs, offering productivity improvements and incorporating sustainable materials to reduce environmental impact and enhance process efficiency. |
| Lonza | Nov-24 | Lonza completed its first GMP manufacturing batch at its next-generation mammalian production facility, marking an operational scale-up in biologics manufacturing. The facility supports both 6,000L and 20,000L bioreactor capacities, enhancing production flexibility and scalability for commercial biologics and strengthening Lonza’s position in advanced biomanufacturing services. |
| Lonza | Nov-24 | Lonza completed a GMP-compliant manufacturing batch at its Portsmouth mammalian production facility using a 2,000L single-use bioreactor system. The site expands capacity for small- to mid-scale biologics production, particularly for rare disease therapies, and integrates advanced process analytics and streamlined workflows to improve commercialization timelines and production reliability. |
| Brevel | Jun-24 | Brevel launched a commercial algae protein production facility designed for large-scale manufacturing of microalgae-based protein ingredients. The facility enables production of hundreds of tons of neutral-tasting, functional protein targeted at alt-dairy and functional food applications, significantly expanding industrial-scale bioreactor-enabled food ingredient production capabilities. |
| Getinge AB | Mar-24 | Getinge AB launched the Single-Use Production Reactor (SUPR) system in 50-liter and 250-liter configurations, expanding its single-use bioreactor portfolio. The system targets bioprocess development and small-scale production, supporting flexible manufacturing approaches in biologics and strengthening Getinge’s position in modular bioprocessing equipment solutions. |
| Merck KGaA | Apr-23 | Merck KGaA launched the Ultimus single-use process container film designed for bioprocessing applications. The material improves durability and leak resistance in single-use bioreactor assemblies, supporting enhanced reliability and operational efficiency in liquid handling and biomanufacturing workflows. |
| Donaldson Company | Nov-21 | Donaldson Company acquired Solaris Biotechnology Srl, a bioprocessing equipment manufacturer specializing in systems ranging from benchtop to commercial-scale bioreactors. The acquisition enhances Donaldson’s life sciences portfolio and strengthens its capabilities across biotechnology, food and beverage, and industrial bioprocessing applications. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Small-scale Bioreactors Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Cell Type | Mammalian Cells, Microbial Cells, Insect Cells, Plant Cells, Stem Cells |
| Bioprocess Stage | Process Development, Media & Process Optimization, Scale-Up Studies, Production Support |
| Cultivation Mode | Batch, Fed-Batch, Continuous & Perfusion |
Small-scale Bioreactors Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Bioprocessing Decentralization Opportunity Assessment |
|
| Research-to-Production Scale-up Strategy Analysis |
|
| Single-use Technology Adoption Evaluation |
|
Need a different cut of the data?
Request Custom ResearchHow big is the small-scale bioreactors market?
How will the small-scale bioreactors industry grow in terms of size and CAGR by 2036?
How is expanding biopharmaceutical R&D driving adoption of small-scale bioreactor systems for process development?
Why is rising adoption of single-use bioreactors increasing operational flexibility in CROs and CMOs?
Why do CROs and CMOs represent the largest end-use segment in the small-scale bioreactors market?
Which capacity segment is growing fastest in the small-scale bioreactors market?
Why is North America the leading market for small-scale bioreactors?
What factors are accelerating small-scale bioreactor demand in Asia Pacific?
Who are the major participants shaping the small-scale bioreactors landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization